DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Poxel Announces Positive Results From Phase SAP.
2a NASH Trial With PXL770, an Oral First-in-Class Direct AMPK Activator. Press Release. 2020
Access:
We do not assume any responsibility for the contents of the web pages of other providers.